Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
8
Frequently Asked Questions
What is Market Cap of Minerva Neurosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Minerva Neurosciences Inc market cap is $15.04M.
What is the 52-week high for Minerva Neurosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Minerva Neurosciences Inc 52 week high is $3.00 as of September 10, 2025.
What is the 52-week low for Minerva Neurosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Minerva Neurosciences Inc 52 week low is $1.15 as of September 10, 2025.
What is Minerva Neurosciences Inc stock price today?
Minerva Neurosciences Inc stock price today is $2.15.
What was Minerva Neurosciences Inc stock price yesterday?
Minerva Neurosciences Inc stock price yesterday was $2.15.
What is the PE ratio of Minerva Neurosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Minerva Neurosciences Inc’s P/E ratio is 1.45.
What is the Price-to-Book ratio of Minerva Neurosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Minerva Neurosciences Inc P/B ratio is -0.4683.
What is the 50-day moving average of Minerva Neurosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Minerva Neurosciences Inc 50-day moving average is $2.01.
How many employess does Minerva Neurosciences Inc has?
